Mölndal, Sweden

Bengt Ohlsson

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.3

ph-index = 1


Location History:

  • Molndal, SE (2014)
  • Mölndal, SE (2004 - 2015)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Bengt Ohlsson

Introduction

Bengt Ohlsson is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune and fibrotic diseases. With a total of 5 patents to his name, Ohlsson's work has had a meaningful impact on medical science.

Latest Patents

Ohlsson's latest patents include innovative pharmaceutical compounds designed to treat various interstitial lung diseases, such as idiopathic pulmonary fibrosis and sarcoidosis. One of his key patents involves selective angiotensin II compounds, which are defined by a specific formula that addresses these complex health issues. Another patent focuses on a compound that also targets autoimmune and fibrotic diseases, showcasing his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Bengt Ohlsson has worked with prominent companies in the pharmaceutical industry, including Albireo AB and Vicore Pharma AB. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical therapies.

Collaborations

Ohlsson has collaborated with several professionals in his field, including Maria Boije and Anders Broo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.

Conclusion

Bengt Ohlsson's contributions to the pharmaceutical industry through his patents and collaborations highlight his dedication to improving healthcare. His innovative work continues to pave the way for new treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…